XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Follow On Public Offering
Common Stock
Common Stock
Follow On Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Follow On Public Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     22,692        
Beginning balance at Dec. 31, 2023 $ 708,052   $ 2   $ 796,450   $ (88,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 45,247       45,247    
Net loss (55,473)           (55,473)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     133        
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 15,054       15,054    
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     133        
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 15,054       15,054    
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     307        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (20,368)       (20,368)    
Ending balance (in shares) at Jun. 30, 2024     23,132        
Ending balance at Jun. 30, 2024 692,512   $ 2   836,383   (143,873)
Beginning balance (in shares) at Mar. 31, 2024     22,872        
Beginning balance at Mar. 31, 2024 696,210   $ 2   813,312   (117,104)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 22,353       22,353    
Net loss (26,769)           (26,769)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     100        
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 12,349       12,349    
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     100        
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 12,349       12,349    
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     160        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (11,631)       (11,631)    
Ending balance (in shares) at Jun. 30, 2024     23,132        
Ending balance at Jun. 30, 2024 $ 692,512   $ 2   836,383   (143,873)
Beginning balance (in shares) at Dec. 31, 2024 23,598   23,598        
Beginning balance at Dec. 31, 2024 $ 699,719   $ 2   881,718   (182,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 55,278       55,278    
Net loss (44,056)           (44,056)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     150 2,012      
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 29,695 $ 387,329 $ 1   29,695 $ 387,328  
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     150 2,012      
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 29,695 387,329 $ 1   29,695 387,328  
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     244        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings $ (27,284)       (27,284)    
Ending balance (in shares) at Jun. 30, 2025 26,004   26,004        
Ending balance at Jun. 30, 2025 $ 1,100,681   $ 3   1,326,735   (226,057)
Beginning balance (in shares) at Mar. 31, 2025     23,722        
Beginning balance at Mar. 31, 2025 692,514   $ 2   898,390   (205,878)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 25,128       25,128    
Net loss (20,179)           (20,179)
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs (in shares)     150 2,012      
Issuance of common stock upon follow-on public offering net of underwriting discounts and commissions and other offering costs 29,695 387,329 $ 1   29,695 387,328  
Issuance of common stock in connection with At-The-Marker offering net of underwriting discounts and commissions and other offerings costs (in shares)     150 2,012      
Issuance of common stock in connection with At-The-Market offering net of underwriting discounts and commissions and other offering costs 29,695 $ 387,329 $ 1   29,695 $ 387,328  
Issuance of shares upon vesting of restricted stock units, net of tax withholdings (in shares)     120        
Issuance of shares upon vesting of restricted stock units, net of tax withholdings $ (13,806)       (13,806)    
Ending balance (in shares) at Jun. 30, 2025 26,004   26,004        
Ending balance at Jun. 30, 2025 $ 1,100,681   $ 3   $ 1,326,735   $ (226,057)